Loading insider details...
Beta
Latest Form 4 (Aug 6, 2026): Grant/Award of 27,000 ATTO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 6, 2026 | Attovia Therapeutics, Inc. (ATTO) | Grant/Award | 27,000 | n/a |
| Jan 6, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/Award | 40,000 | n/a |
| Jun 23, 2025 | Oric Pharmaceuticals, Inc. (ORIC) | Purchase | 26,597 | $249.7K |
| Jan 6, 2025 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/Award | 35,000 | n/a |
| Jun 14, 2024 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/Award | 25,600 | n/a |
| Feb 27, 2024 | RayzeBio, Inc. (RYZB) | Disposition to Issuer | 73,731 | n/a |
| Jun 15, 2023 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/Award | 20,500 | n/a |
| Jun 17, 2022 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/Award | 45,158 | n/a |
| Nov 10, 2021 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/Award | 33,250 | n/a |